Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

Is BROS Stock a Buy at 4x Sales With Coffee Costs Rising?
Is BROS Stock a Buy at 4x Sales With Coffee Costs Rising?

Dutch Bros Inc. BROS is in a classic growth-versus-margins setup. The chain is putting up strong transaction-led demand and building out its footprint, but rising input and occupancy costs can

Super Micro Computer's Rack-Scale AI Push: A New Growth Catalyst?
Super Micro Computer's Rack-Scale AI Push: A New Growth Catalyst?

Super Micro Computer’s SMCI business has evolved from a components and subsystems provider to delivering server and storage systems, then full rack-scale solutions, and is now progressing toward

Here's Why Envela Corporation (ELA) is a Great Momentum Stock to Buy
Here's Why Envela Corporation (ELA) is a Great Momentum Stock to Buy

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Are You Looking for a Top Momentum Pick? Why YPF Sociedad Anonima (YPF) is a Great Choice
Are You Looking for a Top Momentum Pick? Why YPF Sociedad Anonima (YPF) is a Great Choice

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

SNY's Lunsekimig Succeeds in Asthma & CRSwNP Studies, Fails in Eczema
SNY's Lunsekimig Succeeds in Asthma & CRSwNP Studies, Fails in Eczema

Sanofi SNY announced positive data from two separate mid-stage studies (AIRCULES and DUET) evaluating the safety and efficacy of its investigational candidate, lunsekimig, in patients with

Is Valmont (VMI) a Solid Growth Stock? 3 Reasons to Think "Yes"
Is Valmont (VMI) a Solid Growth Stock? 3 Reasons to Think "Yes"

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth

Laureate Education (LAUR) is an Incredible Growth Stock: 3 Reasons Why
Laureate Education (LAUR) is an Incredible Growth Stock: 3 Reasons Why

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock

Can Howmet (HWM) Keep the Earnings Surprise Streak Alive?
Can Howmet (HWM) Keep the Earnings Surprise Streak Alive?

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Howmet (HWM), which belongs to the Zacks

BVFL Upgraded to Outperform on Asset Quality, Loan Growth
BVFL Upgraded to Outperform on Asset Quality, Loan Growth

BV Financial, Inc. BVFL has been upgraded to an “Outperform” rating from “Neutral,” reflecting improving credit trends, a solid capital base and continued expansion in its core lending operations

Stream if You Want to Go Faster: Netflix's New $120 Target
Stream if You Want to Go Faster: Netflix's New $120 Target

In a market often focused on uncertainty, a decisive signal on April 6, 2026, has captured the investment community's attention. Prominent financial institution Goldman Sachs (NYSE: GS) issued a

EQNR Awards Reach Subsea for Development of NCS Using Reach Remote 1
EQNR Awards Reach Subsea for Development of NCS Using Reach Remote 1

Equinor ASA EQNR has awarded Reach Subsea two new contracts under an existing framework agreement. The work will be carried out on the Norwegian Continental Shelf (“NCS”) and will focus on subsea

STXS Gains on FDA Nod for Synchrony System, Expands Digital Surgery
STXS Gains on FDA Nod for Synchrony System, Expands Digital Surgery

Stereotaxis STXS recently announced that the FDA granted 510(k) clearance for its Synchrony system, a next-generation platform aimed at modernizing interventional cath labs.

The Synchrony system is

Quantum IPO Pipeline Reopens: 1 Pure Play and 2 Enablers Stand Out
Quantum IPO Pipeline Reopens: 1 Pure Play and 2 Enablers Stand Out

The quantum computing space is beginning to show early signs of a capital markets inflection, as fresh funding rounds and a gradually reopening IPO pipeline point to improving investor appetite for

Aehr Test Systems (AEHR) Reports Q3 Loss, Misses Revenue Estimates
Aehr Test Systems (AEHR) Reports Q3 Loss, Misses Revenue Estimates

Aehr Test Systems (AEHR) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to earnings of $0.07 per share a year ago. These

Skillsoft Corp. (SKIL) Lags Q4 Earnings Estimates
Skillsoft Corp. (SKIL) Lags Q4 Earnings Estimates

Skillsoft Corp. (SKIL) came out with quarterly earnings of $1.26 per share, missing the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $2.11 per share a year ago. These

Kura Sushi (KRUS) Reports Q2 Loss, Beats Revenue Estimates
Kura Sushi (KRUS) Reports Q2 Loss, Beats Revenue Estimates

Kura Sushi (KRUS) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.14 per share a year ago. These figures are

Compared to Estimates, Levi Strauss (LEVI) Q1 Earnings: A Look at Key Metrics
Compared to Estimates, Levi Strauss (LEVI) Q1 Earnings: A Look at Key Metrics

For the quarter ended February 2026, Levi Strauss (LEVI) reported revenue of $1.74 billion, up 9.3% over the same period last year. EPS came in at $0.42, compared to $0.38 in the year-ago quarter.

How Can You Understand End-to-End Machine Learning Workflows to Succeed in the DP-100 Exam?

How Can You Understand End-to-End Machine Learning Workflows to Succeed in the DP-100 Exam?

Europe MICE Market Competitive Landscape and Strategic Insights
Europe MICE Market Competitive Landscape and Strategic Insights
Europe MICE Market was valued at 278.16 USD Billion in 2024 and is projected to grow from 298.88 USD Billion in 2025 to 613.24 USD Billion by 2035, registering a CAGR of 7.4% during the forecast
Best Income Stocks to Buy for April 8th
Best Income Stocks to Buy for April 8th

Here are two stocks with buy rank and strong income characteristics for investors to consider today, April 8: 

CrossAmerica Partners LP CAPL: This fuel distribution company has witnessed the Zacks